Clinical Trial Update: Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating OCTA-directed PDT triple therapy for exudative age-related macular degeneration has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Exudative Age Related Macular Degeneration | Phase 4 | Status: WITHDRAWN